Sichuan Kelun Pharmaceutical Co. Ltd. | Ownership
Companies that own Sichuan Kelun Pharmaceutical Co. Ltd.
Shanghai J Royal Asset Management Co., Ltd.
23,300,000
2.25%
23,300,000
90.48%
09/30/2017
China Universal Asset Management Co., Ltd.
11,688,950
1.12%
11,574,524
0.41%
12/31/2017
Norges Bank Investment Management
5,856,077
0.56%
5,360,220
0%
12/31/2017
Galaxy Asset Management Co., Ltd.
5,055,172
0.49%
5,055,172
1.19%
12/31/2017
AEGON-INDUSTRIAL Fund Management Co., Ltd.
4,046,018
0.39%
-2,102,923
0.3%
12/31/2017
China Southern Asset Management Co., Ltd.
4,016,778
0.39%
-198,671
0.15%
12/31/2017
Great Wall Fund Management Co., Ltd.
3,262,077
0.32%
3,255,400
0.84%
12/31/2017
Everbright Pramerica Fund Management Co., Ltd.
3,000,000
0.28%
-610,000
0.6%
12/31/2017
Lion Fund Management Co., Ltd.
2,497,293
0.24%
-2,084,387
0.51%
12/31/2017
Bosera Asset Management Co., Ltd.
2,351,229
0.23%
2,341,031
0.08%
12/31/2017
| Address |
No. 36 West Baihua Road
Chengdu Sichuan 610071
China
|
|
Employees
|
- |
| Website |
http://www.kelun.com |
| Updated |
07/08/2019 |
| Sichuan Kelun Pharmaceutical Co., Ltd. engages in manufacture and sale of pharmaceutical products. Its products include IV Solutions, lyophilized, Sterile powders for injection, Tablets, Capsules, Oral Preparations, Injectable Powder, Antipsychotic, Respiratory System, Anti-pathogenic Microorganisms, APIs and Intermediates, SVP and medical devices. It also provides dialysis solutions, APIs, pharmaceutical packaging materials, medical devices, and antibiotic intermediates. |
